PhRMA
MAY 22, 2023
As we’ve discussed on this blog before, the U.S. Food and Drug Administration’s (FDA) accelerated approval program has served as a critical lifeline for patients with serious and life-threatening conditions. The program was originally established at the urging of patient advocates during the height of the HIV/AIDS epidemic, in which patients waited years for the FDA to review and approve new treatments.
Drug Topics
MAY 22, 2023
The approval of Rinvoq (upadacitinib) was based on the results of three clinical trials: two induction therapy studies and one maintenance study.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
MAY 22, 2023
Supportive nurse managers and supervisors as well as nurses’ involvement in organizational governance may help lower hospital-onset Clostridioides difficile infection in acute care hospitals.
Drug Topics
MAY 22, 2023
Active tobacco use and BMI were inversely related to the risk of developing IPD.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
MAY 22, 2023
BOSTON — Scientific journals have become something of a Mad Libs game for GPT: Artificial intelligence can now detect __, or speedily tell the difference between __ and __. But which of these studies are actually important? How can clinicians sort them out from one another? At a recent AI conference, Atman Health chief medical officer and Brigham and Women’s associate physician Rahul Deo boiled the issue down in a single slide: the riskiest, most impactful studies draw far le
Pharmacy Times
MAY 22, 2023
Beremagene geperpavec completely closed severe blistering and wounds in more than half of all patients with dystrophic epidermolysis bullosa with specific mutations.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Fierce Pharma
MAY 22, 2023
Blueprint's Ayvakit picks up long-awaited FDA approval in indolent systemic mastocytosis zbecker Mon, 05/22/2023 - 14:43
STAT
MAY 22, 2023
I once saw a patient who came to the emergency room with injuries that were clearly related to domestic violence. Instead of offering a compassionate ear and a blanket to cover her exposed body after an assault, her intake nurse rushed through a checklist intended to screen her for social needs. While facing the computer screen, the nurse asked the patient a series of sensitive questions, including one about whether she had experienced domestic violence.
Pharmaceutical Technology
MAY 22, 2023
Amid high inflation , the latest banking crisis , and the continued repercussions of Brexit, the talent pool at British universities remains a major draw for British biotech. Now, the country’s possible participation in the EU’s Horizon Europe scheme would serve to boost the industry during a challenging time. Recent negotiations between the UK and the EU have opened the country’s prospects to re-joining the Horizon Europe program, which has been welcomed by biotechs and institutions alike.
PharmExec
MAY 22, 2023
The market for prescription medicines in the United States was subject to major shifts in use across therapeutic areas in 2022, reflecting changes in patient health needs, the development, and availability of novel medicines, and complex market dynamics.
Pharmaceutical Technology
MAY 22, 2023
The ongoing patent litigation between CureVac and Pfizer /BioNTech will move to a court in Virginia following a request from Curevac, potentially bringing forward the trial date to sometime in 2024. The Covid-19 pandemic saw a proliferation in novel vaccine technologies being produced rapidly. With the emergence of vaccines came accusations of technology encroachment amongst biotech companies.
Pharmacy Times
MAY 22, 2023
Many patients with post-COVID-19 condition reported perceived cognitive deficits early during their COVID-19 infection as well.
Pharmaceutical Technology
MAY 22, 2023
The Center for Drug Evaluation (CDE) of China’s National Medical Products Administration (NMPA) has accepted an investigational new drug application (IND) for SinoMab BioScience’s SM17 to treat asthma. SM17 is a humanised IgG4-k monoclonal antibody that targets IL-17RB to treat asthma, idiopathic pulmonary fibrosis (IPF), atopic dermatitis (AD) and other immunological disorders.
Pharmacy Times
MAY 22, 2023
OTC nicotine replacement products can come in a transdermal patch, nicotine gum, or lozenges.
Fierce Healthcare
MAY 22, 2023
Mayo Clinic, Johns Hopkins and 20 others pledge to join TEFCA, prioritize interoperability aburky Mon, 05/22/2023 - 17:13
Fierce Pharma
MAY 22, 2023
Bayer's blockbuster hopeful Nubeqa, AstraZeneca's Forxiga pick up nods from England's NICE zbecker Mon, 05/22/2023 - 10:44
The Checkup by Singlecare
MAY 22, 2023
If you are pregnant or considering becoming pregnant, you may have heard of the Rh factor. You probably want to know if it’s something you need to be concerned about, and you may be confused about what it actually is. This is common—it’s a bit of a confusing concept! Here, we’ll go through the ins and outs of Rh factor, including what it is, what causes it, who is at risk for complications, and what treatment options are available.
STAT
MAY 22, 2023
WASHINGTON — U.S. health regulators on Monday approved a new, easy-to-use version of a medication to reverse overdoses caused by fentanyl and other opioids driving the nation’s drug crisis. Opvee is similar to naloxone , the lifesaving drug that has been used for decades to quickly counter overdoses of heroin, fentanyl, and prescription painkillers.
ISPE
MAY 22, 2023
Asia-Pacific Regulatory & Industry Views on Drug Shortage Prevention Trudy Patterson Mon, 05/22/2023 - 11:34 iSpeak Blog iSpeak Asia-Pacific Regulatory & Industry Views on Drug Shortage Prevention Vivien Santillan Christopher John Potter, PhD 22 May 2023 The ISPE Drug Shortages Initiative Team conducted a webinar on 9 February 2023 to discuss regulatory and industry insights on drug shortage prevention with a focus on the Asia-Pacific region.
STAT
MAY 22, 2023
An oral version of semaglutide, the drug marketed as Ozempic and Wegovy , led to dramatic weight loss in a trial enrolling people with obesity, manufacturer Novo Nordisk said Monday, data that could bolster what is already a blockbuster medicine. In the study, which enrolled nearly 700 adults classified as having overweight or obesity, patients treated with a daily semaglutide tablet lost 15.1% of their body weight over the course of 17 months, while those on placebo lost 2.4%, Novo Nordisk said
Pharmacy Times
MAY 22, 2023
Avapritinib has been FDA approved for the treatment of advanced systemic mastocytosis since June 2021.
STAT
MAY 22, 2023
The area of North Bellport on Long Island sits in the shadows of a massive landfill. This predominantly Black and Latino neighborhood also has the lowest life expectancy on Long Island, as well as the second-highest rates of asthma. Environmental activists do not think this is a coincidence, and for decades they have waged a battle to shut down the Brookhaven Landfill, which they believe is making their community sick.
Drug Topics
MAY 22, 2023
Some patients with PAH need to travel long distances, which may impact their access to quality care providers.
The People's Pharmacy
MAY 22, 2023
The relationship between statin-type cholesterol-lowering drugs and memory problems has been controversial for decades. When we first wrote about a link between drugs like atorvastatin ( Lipitor ), lovastatin ( Mevacor ), or simvastatin ( Zocor ) and forgetfulness or brain fog 22 years ago, we were told it was all in our heads. Some health professionals were outraged that we dared to discuss this issue at all.
Drug Topics
MAY 22, 2023
According to commentaries published in the Annals of Internal Medicine, doctors remain split on the question.
Fierce Pharma
MAY 22, 2023
Pfizer, Moderna among many biopharma giants to post Q1 sales declines, as Novo Nordisk led growth charge kdunleavy Mon, 05/22/2023 - 13:04
Drug Topics
MAY 22, 2023
Exhaled carbon monoxide in vape users significantly decreased between their first and third clinical visits.
STAT
MAY 22, 2023
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because the familiar routine of online meetings, phone calls, and deadlines has predictably returned. But what can you do? The world, such as it is, continues to spin. So to cope, yes, we are brewing cups of stimulation. Our choice so far today is chocolate cappuccino and, as always, we welcome you to join us.
Drug Topics
MAY 22, 2023
A higher dose of the carbonic anhydrase inhibitor does not seem to provide any additional improvements.
Drug Store News
MAY 22, 2023
The Excellence in Innovation Award recognizes qualified pharmacists who have demonstrated significant innovation in their practice, method or service.
Hospital Pharmacy Europe
MAY 22, 2023
NICE has recommended the extension of dapagliflozin as a treatment option for symptomatic chronic heart failure in patients with preserved or mildly reduced ejection fraction. In final draft guidelines , the committee said it had reviewed evidence from AstraZeneca that adding dapagliflozin (Forxiga) to standard care with diuretics reduces the combined risk of dying from cardiovascular causes or hospital admission with heart failure.
Drug Store News
MAY 22, 2023
Cefaly Technology is offering Cefaly, an FDA-cleared, over-the-counter wearable medical device that aims to help relieve migraine pain and reduce frequency.
European Pharmaceutical Review
MAY 22, 2023
A review by Swedish researchers has identified the benefits of smart contracts on blockchain platforms in the pharmaceutical supply chain and its role in combating counterfeit drugs. While the counterfeit market is estimated to be a market of over $200 billion and despite its benefits, blockchain technology has not been fully implemented in the pharmaceutical supply chain, according to the paper.
Fierce Pharma
MAY 22, 2023
With Dupixent leading the way, Sanofi’s taking on the 'big players' in respiratory diseases: exec kdunleavy Mon, 05/22/2023 - 07:33
Hospital Pharmacy Europe
MAY 22, 2023
More transparency is needed about where General Pharmaceutical Council (GPhC) fees are spent if pharmacy professionals are to be asked to pay more, pharmacy representatives have said. Last week, the GPhC proposed raising its fees by 7.5% – meaning that from April 2024, the pharmacist registration renewal fee would increase by £19, from £257 to £276.
Pharmaceutical Technology
MAY 22, 2023
The European Medicines Agency (EMA) has accepted and verified Sobi’s marketing authorisation application for a new factor VIII (FVIII), efanesoctocog alfa, to treat haemophilia A patients of all ages. The application is supported by results from the Phase III XTEND-1 trial in adults and adolescents and backed by the XTEND-Kids paediatric trial in patients aged under 12 years.
Expert insights. Personalized for you.
214 
Let's personalize your content